Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
3.60
Dollar change
+0.13
Percentage change
3.90
%
Index- P/E- EPS (ttm)-2.46 Insider Own17.16% Shs Outstand8.15M Perf Week10.43%
Market Cap29.92M Forward P/E- EPS next Y-2.69 Insider Trans0.00% Shs Float6.88M Perf Month26.56%
Income-20.05M PEG- EPS next Q-0.75 Inst Own8.89% Short Float0.35% Perf Quarter18.81%
Sales0.00M P/S- EPS this Y-19.38% Inst Trans-20.82% Short Ratio1.48 Perf Half Y22.03%
Book/sh5.18 P/B0.70 EPS next Y12.82% ROA-35.01% Short Interest0.02M Perf Year-18.18%
Cash/sh5.22 P/C0.69 EPS next 5Y- ROE-38.58% 52W Range1.95 - 4.53 Perf YTD31.87%
Dividend Est.- P/FCF- EPS past 5Y36.51% ROI-46.54% 52W High-20.58% Beta1.24
Dividend TTM- Quick Ratio8.92 Sales past 5Y0.00% Gross Margin- 52W Low84.62% ATR (14)0.24
Dividend Ex-Date- Current Ratio8.92 EPS Y/Y TTM77.76% Oper. Margin0.00% RSI (14)64.63 Volatility9.69% 7.92%
Employees25 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price14.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q15.93% Payout- Rel Volume2.46 Prev Close3.46
Sales Surprise- EPS Surprise10.34% Sales Q/Q- EarningsMay 09 AMC Avg Volume16.37K Price3.60
SMA2015.44% SMA5021.63% SMA20034.99% Trades Volume40,245 Change3.90%
Jun-14-24 09:20AM
09:19AM
Jun-13-24 08:30AM
May-28-24 08:30AM
May-20-24 03:58PM
11:14AM Loading…
11:14AM
08:30AM
May-13-24 10:45AM
May-10-24 12:39PM
12:10PM
May-09-24 05:47PM
04:05PM
May-08-24 08:00AM
May-02-24 08:00AM
Apr-23-24 10:48AM
09:48AM Loading…
09:48AM
07:30AM
Apr-10-24 09:53AM
Apr-09-24 08:30AM
Apr-03-24 08:30AM
Mar-22-24 12:25PM
Mar-21-24 08:00AM
Mar-08-24 08:35AM
Mar-05-24 08:35AM
Mar-04-24 08:00AM
Mar-02-24 08:29AM
Mar-01-24 08:29AM
Feb-29-24 04:05PM
Feb-22-24 08:00AM
Feb-20-24 08:00AM
12:12PM Loading…
Jan-23-24 12:12PM
Jan-18-24 08:30AM
Jan-17-24 08:00AM
Jan-04-24 08:00AM
Dec-12-23 08:00AM
Nov-28-23 04:05PM
Nov-09-23 04:05PM
Nov-07-23 12:00PM
Nov-05-23 12:18PM
Nov-03-23 07:50AM
Nov-02-23 04:05PM
Oct-26-23 08:00AM
Oct-24-23 08:00AM
Oct-18-23 11:13AM
Oct-17-23 08:00AM
Sep-28-23 08:00AM
Sep-20-23 08:00AM
Sep-12-23 08:00AM
Sep-07-23 12:58PM
Sep-06-23 08:00AM
Sep-05-23 08:00AM
Aug-19-23 07:52AM
Aug-15-23 11:58PM
08:30AM
Aug-14-23 04:05PM
Aug-08-23 08:00AM
Aug-07-23 08:30AM
Jul-11-23 08:30AM
Jun-12-23 08:30AM
May-24-23 08:00AM
May-09-23 04:05PM
07:15AM
May-02-23 09:07AM
Apr-27-23 09:00AM
Apr-20-23 08:30AM
08:13AM
Apr-19-23 08:30AM
Apr-18-23 08:30AM
Apr-05-23 09:34AM
Mar-30-23 04:05PM
Mar-23-23 08:30AM
Mar-10-23 08:35AM
Mar-07-23 08:35AM
Mar-06-23 09:00AM
Feb-01-23 08:30AM
Nov-10-22 04:05PM
Nov-07-22 08:00AM
Nov-03-22 08:00AM
Oct-06-22 08:30AM
Sep-29-22 08:00AM
Sep-16-22 08:35AM
Sep-15-22 09:15AM
Lisata Therapeutics, Inc. is engaged in the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. It also actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor, while normal tissues are unlikely to be affected. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.